Literature DB >> 10716924

Functional HLA-DM on the surface of B cells and immature dendritic cells.

S O Arndt1, A B Vogt, S Markovic-Plese, R Martin, G Moldenhauer, A Wölpl, Y Sun, D Schadendorf, G J Hämmerling, H Kropshofer.   

Abstract

HLA-DM (DM) plays a critical role in antigen presentation through major histocompatibility complex (MHC) class II molecules. DM functions as a molecular chaperone by keeping class II molecules competent for antigenic peptide loading and serves as an editor by favoring presentation of high-stability peptides. Until now, DM has been thought to exert these activities only in late endosomal/lysosomal compartments of antigen-presenting cells. Here we show that a subset of DM resides at the cell surface of B cells and immature dendritic cells. Surface DM engages in complexes with putatively empty class II molecules and controls presentation of those antigens that rely on loading on the cell surface or in early endosomal recycling compartments. For example, epitopes derived from myelin basic protein that are implicated in the autoimmune disease multiple sclerosis are down-modulated by DM, but are presented in the absence of DM. Thus, this novel concept of functional DM on the surface may be relevant to both protective immune responses and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716924      PMCID: PMC305665          DOI: 10.1093/emboj/19.6.1241

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  81 in total

1.  EEA1 links PI(3)K function to Rab5 regulation of endosome fusion.

Authors:  A Simonsen; R Lippé; S Christoforidis; J M Gaullier; A Brech; J Callaghan; B H Toh; C Murphy; M Zerial; H Stenmark
Journal:  Nature       Date:  1998-07-30       Impact factor: 49.962

2.  Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function.

Authors:  R Busch; R C Doebele; E von Scheven; J Fahrni; E D Mellins
Journal:  J Immunol       Date:  1998-01-15       Impact factor: 5.422

3.  Human monoclonal antibody with T-cell-like specificity recognizes MHC class I self-peptide presented by HLA-DR1 on activated cells.

Authors:  A Wölpl; T Halder; H Kalbacher; H Neumeyer; K Siemoneit; S F Goldmann; T H Eiermann
Journal:  Tissue Antigens       Date:  1998-03

4.  Identification of a sequence that mediates promiscuous binding of invariant chain to MHC class II allotypes.

Authors:  I M Siebenkotten; C Carstens; N Koch
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

5.  Peptide loading onto recycling HLA-DR molecules occurs in early endosomes.

Authors:  V M Pinet; E O Long
Journal:  Eur J Immunol       Date:  1998-03       Impact factor: 5.532

Review 6.  The diversity of Rab proteins in vesicle transport.

Authors:  P Novick; M Zerial
Journal:  Curr Opin Cell Biol       Date:  1997-08       Impact factor: 8.382

7.  Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes.

Authors:  S Tourne; T Miyazaki; P Wolf; H Ploegh; C Benoist; D Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

8.  Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells.

Authors:  M Cella; A Engering; V Pinet; J Pieters; A Lanzavecchia
Journal:  Nature       Date:  1997-08-21       Impact factor: 49.962

9.  Negative regulation by HLA-DO of MHC class II-restricted antigen processing.

Authors:  L K Denzin; D B Sant'Angelo; C Hammond; M J Surman; P Cresswell
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

10.  A dominant-negative clathrin mutant differentially affects trafficking of molecules with distinct sorting motifs in the class II major histocompatibility complex (MHC) pathway.

Authors:  S H Liu; M S Marks; F M Brodsky
Journal:  J Cell Biol       Date:  1998-03-09       Impact factor: 10.539

View more
  15 in total

1.  Function-related regulation of the stability of MHC proteins.

Authors:  A Simon; Z s Dosztányi; E Rajnavölgyi; I Simon
Journal:  Biophys J       Date:  2000-11       Impact factor: 4.033

2.  Differing processing requirements of four recombinant antigens containing a single defined T-cell epitope for presentation by major histocompatibility complex class II.

Authors:  L Colledge; M Y Sun ; W Lin; C C Blackburn; P A Reay
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

Review 3.  Diversity in MHC class II antigen presentation.

Authors:  John H Robinson; Alexei A Delvig
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

Review 4.  The expression of HLA-DO (H2-O) in B lymphocytes.

Authors:  Xinjian Chen; Peter E Jensen
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

5.  Major histocompatibility class II molecules prevent destructive processing of exogenous peptides at the cell surface of macrophages for presentation to CD4 T cells.

Authors:  Alexei von Delwig; Julie A Musson; Joe Gray; Norman McKie; John H Robinson
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

Review 6.  How B cells capture, process and present antigens: a crucial role for cell polarity.

Authors:  Maria-Isabel Yuseff; Paolo Pierobon; Anne Reversat; Ana-Maria Lennon-Duménil
Journal:  Nat Rev Immunol       Date:  2013-07       Impact factor: 53.106

7.  Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4+ T cell activation.

Authors:  Miguel Álvaro-Benito; Eliot Morrison; Friederike Ebner; Esam T Abualrous; Marie Urbicht; Marek Wieczorek; Christian Freund
Journal:  Cell Mol Immunol       Date:  2018-11-22       Impact factor: 11.530

8.  Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patient.

Authors:  J P Banga; J K Moore; N Duhindan; A M Madec; P M van Endert; J Orgiazzi; J Endl
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

9.  Reconstruction of a pathway of antigen processing and class II MHC peptide capture.

Authors:  Catherine X Moss; Timothy I Tree; Colin Watts
Journal:  EMBO J       Date:  2007-03-29       Impact factor: 11.598

10.  Unconventional T-cell recognition of an arthritogenic epitope of proteoglycan aggrecan released from degrading cartilage.

Authors:  Jane Falconer; Rahul Mahida; Divya Venkatesh; Jeffrey Pearson; John H Robinson
Journal:  Immunology       Date:  2015-12-21       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.